Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.


Erwan Martin

MBA, Vice-President Finance & Corporate Development
With over 20 years of professional experience in the field of finance and biotechnology, Erwan Martin is an expert in financial and business development matters.


He joined Genomic Vision as Administrative and Financial Director before being appointed Financial and Development Director in 2011.

Erwan Martin began his career as an analyst, then as a project manager for ten years at Syndex, a firm specialising in auditing and consulting in work councils. In 2000, he co-founded Cytomics Pharmaceuticals, a biotechnology company specialising in the discovery of new medicines.

Erwan Martin holds an MBA from Warwick Business School (United Kingdom). He is also a graduate of the Ecole Supérieure de Commerce (ESC) de Toulouse.